By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...
Embattled genetics testing giant 23andMe is thinking of selling itself as it runs out of cash. The company needs ...
Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback